Annual Drug Patent Expirations for BORTEZOMIB
Bortezomib is a drug marketed by Accord Hlthcare, Apotex, Baxter Hlthcare Corp, Dr Reddys, Eugia Pharma, Fresenius Kabi Usa, Hetero Labs Ltd Vi, Hospira, Jiangsu Hansoh Pharm, Meitheal, MSN, Mylan Labs Ltd, Pharmascience Inc, Qilu Pharm Hainan, Sandoz, Scinopharm Taiwan, Teva Pharms Usa, Waverley Pharma Inc, Zydus Pharms, and Maia Pharms Inc and, and is included in twenty-four NDAs. It is available from twenty suppliers. There are three patents protecting this drug.
This drug has five patent family members in four countries.
The generic ingredient in BORTEZOMIB is bortezomib. Twenty suppliers are listed for this compound. There is one tentative approval for this compound. Additional details are available on the bortezomib profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
